Tesamorelin
Tesamorelin is a GHRH analogue studied in research involving growth-hormone signalling, IGF-1 pathways and body-composition biology.
Research overview
Tesamorelin is a synthetic analogue of growth-hormone-releasing hormone (GHRH). It acts at pituitary GHRH receptors and has been studied for its effects on pulsatile growth-hormone release, IGF-1 signalling and body-composition biology.
Evidence status
Tesamorelin has human clinical-trial data and an established pharmacology literature. Research context should still distinguish approved indications from broader experimental questions.
Areas under investigation
- GHRH-receptor signalling
- Growth-hormone and IGF-1 pathways
- Body-composition and metabolic physiology
Explore the scientific literature
For primary-source reading, search the indexed biomedical literature and registered clinical studies. These links are provided as research gateways rather than endorsements of any particular finding.